Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VarCT Diagnostics is developing highly sensitive and specific in vitro diagnostics for early detection and therapy stratification in cancers with high unmet needs. Their technology leverages first-in-class antibodies and recombinant proteins targeting oncofetal chondroitin sulfate, a biomarker re-expressed in multiple tumor types. Initial results include successful identification of circulating tumor cells and extracellular vesicles bearing this marker in blood samples from patients with prostate, pancreatic, and liver cancers. The company is expanding its portfolio to additional cancer indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VarCT Diagnostics.